000			01964 a2200481 4500
005			20250515171305.0
264		0	_c20090813
008			200908s 0 0 eng d
022			_a1874-4745
024	7		_a10.2174/1874473710801030303 _2doi
040			_aNLM _beng _cNLM
100	1		_aXi, Zheng-Xiong
245	0	0	_aHypothesis-driven medication discovery for the treatment of psychostimulant addiction. _h[electronic resource]
260			_bCurrent drug abuse reviews _cNov 2008
300			_a303-27 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, N.I.H., Intramural; Review
650	0	4	_aAnimals
650	0	4	_aBrain _xdrug effects
650	0	4	_aCannabinoid Receptor Modulators _xmetabolism
650	0	4	_aCentral Nervous System Stimulants
650	0	4	_aCocaine-Related Disorders _xdiagnosis
650	0	4	_aDopamine _xmetabolism
650	0	4	_aDopamine Agonists _xadverse effects
650	0	4	_aDopamine Antagonists _xadverse effects
650	0	4	_aDrug Evaluation, Preclinical
650	0	4	_aExcitatory Amino Acid Agonists _xadverse effects
650	0	4	_aGABA Agonists _xadverse effects
650	0	4	_aGABA Uptake Inhibitors
650	0	4	_aGlutamic Acid _xmetabolism
650	0	4	_aHumans
650	0	4	_aNarcotic Antagonists _xadverse effects
650	0	4	_aReceptors, AMPA _xantagonists & inhibitors
650	0	4	_aReceptors, N-Methyl-D-Aspartate _xantagonists & inhibitors
650	0	4	_aSerotonin Antagonists _xadverse effects
650	0	4	_aSerotonin Receptor Agonists
650	0	4	_aSubstance-Related Disorders _xdiagnosis
650	0	4	_aTreatment Outcome
650	0	4	_aVesicular Monoamine Transport Proteins _xantagonists & inhibitors
650	0	4	_agamma-Aminobutyric Acid _xmetabolism
700	1		_aGardner, Eliot L
773	0		_tCurrent drug abuse reviews _gvol. 1 _gno. 3 _gp. 303-27
856	4	0	_uhttps://doi.org/10.2174/1874473710801030303 _zAvailable from publisher's website
999			_c18858571 _d18858571